Electrocardiographic effects of diagnostic imaging agents.
Berlex Laboratories, Montville, NJ 07470-1000, USA.
J
J
Wiggins
R
R
Beckmann
H J
HJ
Weinmann
R
R
Lehr
D000200:Action Potentials; D000818:Animals; D003287:Contrast Media / Q000494:pharmacology*; D017023:Coronary Angiography; D003974:Diatrizoate Meglumine / Q000494:pharmacology; D004285:Dogs; D004562:Electrocardiography / Q000187:drug effects*; D005682:Gadolinium; D019786:Gadolinium DTPA / Q000494:pharmacology; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D006571:Heterocyclic Compounds / Q000494:pharmacology; D006801:Humans; D007472:Iohexol / Q000031:analogs & derivatives* / Q000494:pharmacology; D009942:Organometallic Compounds / Q000494:pharmacology; D011446:Prospective Studies; D012307:Risk Factors
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D003974:Diatrizoate Meglumine; D007472:Iohexol; C038192:iopromide; D005682:Gadolinium; D019786:Gadolinium DTPA